Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC allocates funds to boost North Korean healthcare:

This article was originally published in Clinica

Executive Summary

North Korea is to benefit from European Commission funds to purchase medical kits and relaunch the production of intravenous fluids in five hospitals. The Commission is allocating a total of E1.9 million ($1.7 million) for essential health actions in North Korea, which is suffering a continuing humanitarian crisis, linked to structural economic deficiencies. The Danish Red Cross/ IFRC will help with the supply of medical kits to over 1,700 health institutions in North Korea, while the French NGO Premiere Urgence will support the production of intravenous fluids.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064149

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel